Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • US-based heart centre to trial Artrya’s software for heart disease diagnosis
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • US-based heart centre to trial Artrya’s software for heart disease diagnosis
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • US-based heart centre to trial Artrya’s software for heart disease diagnosis
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • US-based heart centre to trial Artrya’s software for heart disease diagnosis
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • US-based heart centre to trial Artrya’s software for heart disease diagnosis
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • Auditors slam Sky and Space, possibly the most hated company listed on the ASX
    • News

    Auditors slam Sky and Space, possibly the most hated company listed on the ASX

    Having been in a voluntary trading halt since last trading on 3 April 2019, shareholders of Sky and Space Global (ASX: SAS) may finally have some closure with signs now pointing to the Israeli-based space company being put into administration.  Earlier in the year, we brought attention to the series of capital raises undertaken by

    Read More
    Public
  • Morrison Government confirms $5m funding towards AI facial recognition for pain assessment
    • News

    Morrison Government confirms $5m funding towards AI facial recognition for pain assessment

    Confirming their commitment announced in April 2019, the Morrison Government has signed a $5 million grant to Australian medtech company PainChek (ASX: PCK) which will provide dementia patients with licences to utilise the facial recognition software for the purpose of assessing pain.  Key to the software which has been clinically tested is its ability to

    Read More
    Public
  • Neuren secures European patent for drug aimed to treat incurable brain disorders
    • News

    Neuren secures European patent for drug aimed to treat incurable brain disorders

    Australian biopharmaceuticals developer Neuren Pharmaceuticals (ASX: NEU) has been granted a patent from the European Patent Office covering NNZ-2591, a world-first drug being developed to treat three neurodevelopmental disorders which affect children, and are currently incurable.  The granting of the new patent is the third jurisdiction to do so for Neuren with the same application

    Read More
    Public
  • Amaysim acquires Jeenee Mobile, increases recurring subscribers to 698k
    • News

    Amaysim acquires Jeenee Mobile, increases recurring subscribers to 698k

    Telecommunications provider amaysim (ASX: AYS) has strengthened its recurring mobile subscriber base through the acquisition of Jeenee Communications and its 41,700 subscribers.  The purchase of the privately-held mobile virtual network operator (MVNO) for total consideration of $7.8 million will take amaysim’s total recurring mobile subscriber base to 698,600 total users with Jeenee customers to be

    Read More
    Public
  • Quantify Tech secures $500k order to turn apartments into SmartHomes
    • News

    Quantify Tech secures $500k order to turn apartments into SmartHomes

    Australian tech manufacturer Quantify Technology (ASX: QFY) has secured an order in excess of $500,000 for their qDevices which will be installed in three apartment buildings, converting them into SmartHomes where lighting and sound will be adjustable by occupants via voice, app and touch.  The Heads of Agreement (HoA) is with Sydney based building developer

    Read More
    Public
  • Apiam Animal Health acquires leading animal consulting business in Victoria
    • News

    Apiam Animal Health acquires leading animal consulting business in Victoria

    In an offer too good to refuse, owners of privately-held veterinary company Grampians Animal Health have sold the business to Apiam Animal Health (ASX: AHX) for $4.65m.  Located in Hamilton, Victoria – the heartland of Victorian sheep farming – the purchase will see Apiam acquire the animal veterinary clinic as well as Livestock Logic, a

    Read More
    Public
  • Linius adds NBL as client for video personalisation service
    • News

    Linius adds NBL as client for video personalisation service

    Australian video tech company Linius (ASX: LNU) has secured Australia’s National Basketball League (NBL) to its growing list of sports clients utilising their personalised video service – Video Virtualization Engine™ (VVE).  As the world’s first service which transforms static video into personalised video experiences, individual users of the VVE technology will be able to individually

    Read More
    Public
  • De.mem adds $1.7m revenue from contract with global powerhouse Givaudan
    • News

    De.mem adds $1.7m revenue from contract with global powerhouse Givaudan

    Australian-Singapore wastewater treatment company De.mem (ASX: DEM) has strengthened its bottom line having today announced a new contract acquisition from Swiss cosmetics and fragrances manufacturer Givaudan (SWX: GVN), valued at a minimum of $1.7m.  The contract will see De.mem operate a wastewater treatment system at the Swiss conglomerate’s Singapore production facility, treating wastewater to meet

    Read More
    Public
  • Wellness and Beauty Solutions, secures NZ mass distributor for TANNED range
    • News

    Wellness and Beauty Solutions, secures NZ mass distributor for TANNED range

    Australian beauty product manufacturer Wellness and Beauty Solutions (ASX: WNB) has secured a partnership with Sisterhood Beauty for mass distribution of their TANNED product range across 600 retail outlets in New Zealand.  Launched in June 2019, the TANNED product line is a safe sunless tanning product which is currently available in Australia via Sportsgirl retail

    Read More
    Public
  • Aus music tech company Jaxta launches first revenue generating platform
    • News

    Aus music tech company Jaxta launches first revenue generating platform

    Music technology company, Jaxsta (ASX: JXT), have today announced the launch of their first revenue generating product, Jaxsta Pro (beta version).  Jaxsta Pro, the monthly subscription-based platform, will be aimed at professionals in the music industry and allow them to manage their online profiles, access market insights, and receive music chart alerts, among other features

    Read More
    Public
  • «
  • ‹
  • 303
  • 304
  • 305
  • 306
  • 307
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.